155 related articles for article (PubMed ID: 11289160)
1. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth.
Tome ME; Baker AF; Powis G; Payne CM; Briehl MM
Cancer Res; 2001 Mar; 61(6):2766-73. PubMed ID: 11289160
[TBL] [Abstract][Full Text] [Related]
2. Changes in phosphate metabolism in thymoma cells suggest mechanisms for resistance to dexamethasone-induced apoptosis. A 31P NMR spectroscopic study of cell extracts.
Lutz NW; Tome ME; Aiken NR; Briehl MM
NMR Biomed; 2002 Aug; 15(5):356-66. PubMed ID: 12203227
[TBL] [Abstract][Full Text] [Related]
3. Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis.
Tome ME; Briehl MM
Cell Death Differ; 2001 Sep; 8(9):953-61. PubMed ID: 11526450
[TBL] [Abstract][Full Text] [Related]
4. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.
Miyashita T; Reed JC
Cancer Res; 1992 Oct; 52(19):5407-11. PubMed ID: 1394146
[TBL] [Abstract][Full Text] [Related]
5. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo.
Baker A; Payne CM; Briehl MM; Powis G
Cancer Res; 1997 Nov; 57(22):5162-7. PubMed ID: 9371519
[TBL] [Abstract][Full Text] [Related]
6. A redox-inactive thioredoxin reduces growth and enhances apoptosis in WEHI7.2 cells.
Freemerman AJ; Powis G
Biochem Biophys Res Commun; 2000 Jul; 274(1):136-41. PubMed ID: 10903908
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
Runnebaum IB; Brüning A
Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance.
Tome ME; Lutz NW; Briehl MM
Biochim Biophys Acta; 2004 Jul; 1693(1):57-72. PubMed ID: 15276325
[TBL] [Abstract][Full Text] [Related]
11. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
Thompson EA
Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis.
Wang Z; Rong YP; Malone MH; Davis MC; Zhong F; Distelhorst CW
Oncogene; 2006 Mar; 25(13):1903-13. PubMed ID: 16301999
[TBL] [Abstract][Full Text] [Related]
13. Increased activity of catalase in tumor cells overexpressing IGFBP-2.
Hoeflich A; Fettscher O; Preta G; Lahm H; Kolb HJ; Wolf E; Weber MM
Horm Metab Res; 2003; 35(11-12):816-21. PubMed ID: 14710363
[TBL] [Abstract][Full Text] [Related]
14. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
Davoodpour P; Landström M; Welsh M
BMC Cancer; 2007 Aug; 7():161. PubMed ID: 17697368
[TBL] [Abstract][Full Text] [Related]
15. Changes in glucocorticoid-induced apoptosis and in expression of Bcl-2 protein during long-term culture of thymic lymphoma.
Kobzdej M; Matuszyk J; Zioło E; Strzadała L
Arch Immunol Ther Exp (Warsz); 2000; 48(1):43-6. PubMed ID: 10722231
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells.
Ramdas J; Liu W; Harmon JM
Cancer Res; 1999 Mar; 59(6):1378-85. PubMed ID: 10096574
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin.
Berggren MI; Husbeck B; Samulitis B; Baker AF; Gallegos A; Powis G
Arch Biochem Biophys; 2001 Aug; 392(1):103-9. PubMed ID: 11469800
[TBL] [Abstract][Full Text] [Related]
18. Glucose 6-phosphate dehydrogenase overexpression models glucose deprivation and sensitizes lymphoma cells to apoptosis.
Tome ME; Johnson DB; Samulitis BK; Dorr RT; Briehl MM
Antioxid Redox Signal; 2006; 8(7-8):1315-27. PubMed ID: 16910779
[TBL] [Abstract][Full Text] [Related]
19. Endogenously generated hydrogen peroxide is required for execution of melphalan-induced apoptosis as well as oxidation and externalization of phosphatidylserine.
Matsura T; Kai M; Jiang J; Babu H; Kini V; Kusumoto C; Yamada K; Kagan VE
Chem Res Toxicol; 2004 May; 17(5):685-96. PubMed ID: 15144226
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
De Milito A; Iessi E; Logozzi M; Lozupone F; Spada M; Marino ML; Federici C; Perdicchio M; Matarrese P; Lugini L; Nilsson A; Fais S
Cancer Res; 2007 Jun; 67(11):5408-17. PubMed ID: 17545622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
